the pharmacokinetics of daunorubicin and doxorubicin were studied in plasma and leukemic cells from 16 patients with acute nonlymphoblastic leukemia during 19 courses of treatment with the unconjugated or dna-conjugated drugs .
C0011015
daunorubicin
C0013089
doxorubicin